Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00909207 · ClinicalTrials.gov registry record
Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing
A clinical trial of Solid Tumors and Hematologic Diseases, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 20
- Enrollment target
- 4
- Study locations
NCT00909207 is a study of Solid Tumors and Hematologic Diseases that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT00909207, a study of Solid Tumors and Hematologic Diseases, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 4
- Study locations
Study Summary
The scientific aim of this study is to evaluate patient comprehension of the 77 newly developed items as well as the extent to which the items correspond to the concepts of interest for each patient reported outcome (PRO). A secondary aim of this study is to evaluate the usability of the technology interface for collecting the PRO data of the PRO-CTCAE system once it has been built to accommodate the learning garnered during the cognitive interviews.
Conditions Studied
Interventions
- BEHAVIORAL Interview
Study Locations (4)
Massachusetts
- Dana-Farber Cancer Institute - Boston
New York
- Memorial Sloan-Kettering Cancer Center - New York
North Carolina
- Duke University Medical Center - Durham
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00909207
The ClinicalTrials.gov registry entry for NCT00909207 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (93% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT00909207 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00909207 about?
NCT00909207 is a clinical study titled "Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing". The scientific aim of this study is to evaluate patient comprehension of the 77 newly developed items as well as the extent to which the items correspond to the concepts of interest for each patient reported outcome (PRO). A secondary aim of this study is to evaluate the usability of the technology...
What is the current status of trial NCT00909207?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2009-07.
What conditions does trial NCT00909207 study?
This clinical trial studies the following conditions: Solid Tumors, Hematologic Diseases, Advanced Cancers.
What interventions are being tested in trial NCT00909207?
The interventions under investigation include: Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00909207?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00909207 being conducted?
This trial has 4 study locations across Massachusetts, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
RECRUITING · Phase 4
-
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of INCB123667 in Subjects With Advanced Solid Tumors
RECRUITING · Phase 1
-
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.